PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
PSKCX
Price
$23.22
Change
-$0.11 (-0.47%)
Updated
Jun 2 closing price
Net Assets
429.22M
Interact to see
Advertisement

PMBCX vs PSKCX

Header iconPMBCX vs PSKCX Comparison
Open Charts PMBCX vs PSKCXBanner chart's image
PMBCX vs PSKCX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. PSKCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and PSKCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. PSKCX (429M). PMBCX (0.00) and PSKCX (0.00) have matching dividends . PMBCX was incepted earlier than PSKCX: PMBCX (19 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than PMBCX (1.71). PSKCX is a more actively managed with annual turnover of: 27.00 vs. PMBCX (13.70). PMBCX has a lower initial minimum investment than PSKCX: PMBCX (1000) vs PSKCX (2500). PMBCX annual gain was more profitable for investors over the last year : -15.11 vs. PSKCX (-47.94). PMBCX return over 5 years is better than : -9.16 vs. PSKCX (-53.44).
PMBCXPSKCXPMBCX / PSKCX
Total Expense Ratio1.712.0484%
Annual Report Gross Expense Ratio1.712.0484%
Fund Existence19 years25 years-
Gain YTD-7.252-4.346167%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets24.6B429M5,734%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.11-47.9432%
Returns for 3 years9.97-38.28-26%
Returns for 5 years-9.16-53.4417%
Returns for 10 years53.2027.56193%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity